Dermocosmetics accounted for €3.1 billion in pharmacy sales over a 12-month period ending in 2025 (IQVIA), but nearly one-third of parapharmacy sales occur outside of pharmacies (Xerfi). Customers check the prices of brands they’re familiar with, phone in hand. Matching prices everywhere erodes the department’s profit margin; failing to monitor prices creates an image of an expensive pharmacy.
White paper
Dermocosmetics: Compare with online retailers and supermarkets
This white paper proposes a method for achieving flawless performance on a short list of benchmark products and accepting a limited margin of error on products where advice makes the difference: two scores per product, four roles, a three-circle comparison matrix, and a price index by role. Figures verified and dated from 2024 to 2026 (IQVIA, Xerfi, Cour des comptes, Ifop, YouGov, Public Health Code).
By downloading it, you will discover
- Why customers compare a few products, not your entire section: 59% of French people feel that their spending at pharmacies has increased, but 61% of those who buy cosmetics at pharmacies remain loyal to the products they know
- How to categorize each item into four roles: shelf markers, featured items, recommended items, and back-of-the-shelf items
- How does it compare to the same product at big-box stores, online retailers, and competitors?
- How to Interpret a Price Index by Role, Weighted by Your Sales, and Fund Benchmarks Through Consulting
- To what extent can a firm justify a price difference, and what does the Code of Ethics—amended in March 2026—allow?
Free download
Get the white paper by email.
Thank you! We'll send you the white paper by email very soon.
Oops! Something went wrong while submitting the form.
By downloading, you agree to be contacted by Booper regarding this content. Your data will never be shared with third parties.